正大生物(03839)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

03839 正大生物

已收盘 08-21 15:50:01

8.710

+0.135

+1.57%

最高8.725	最低8.650	成交量1,000
今开8.650	昨收8.575	日振幅0.87%
总市值20.99亿	流通市值20.97亿	总股本2.41亿
成交额8,687	换手率0.00%	流通股本2.41亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"03839","market":"HK","secType":"STK","nameCN":"正大生物","latestPrice":8.71,"timestamp":1787298601122,"preClose":8.575,"halted":0,"volume":1000,"delay":0,"changeRate":0.015743440233236334,"floatShares":240718310,"shares":241000000,"eps":0.1265,"marketStatus":"已收盘","change":0.135,"latestTime":"08-21 15:50:01","open":8.65,"high":8.725,"low":8.65,"amount":8687,"amplitude":0.008746,"askPrice":8.71,"askSize":1500,"bidPrice":8.65,"bidSize":500,"shortable":0,"etf":0,"ttmEps":0.971459,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787535000000},"marketStatusCode":5,"adr":0,"listingDate":1435852800000,"exchange":"SEHK","adjPreClose":8.575,"openAndCloseTimeList":[[1787275800000,1787284800000],[1787288400000,1787299200000]],"volumeRatio":0.069137,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03839","defaultTab":"news","newsList":[{"id":"1120176823","title":"正大生物(03839)公布两项持续关连交易　HOEL采购年销上限最高7.29亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1120176823","media":"公告速递","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1120176823?lang=zh_cn&edition=full","pubTime":"2026-08-11 19:40","pubTimestamp":1786448439,"startTime":"0","endTime":"0","summary":"2026年8月11日，正大生物控股有限公司公告称，公司分别与 High Orient Enterprises Limited及 CPF  Private Limited签订新的持续关连交易总协议，涵盖2027年至2029年向HOEL销售动保化药等产品，以及2026年至2028年向CPF(印度)采购原料及相关生物科技产品，并公布未来年度交易上限。公司表示，两项协议有助持续满足HOEL集团对CPBIO产品的需求，并确保正大生物获得具竞争力的原料供应，从而支持业务增长和运营稳定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03839"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658997318","title":"正大生物(03839.HK)公布中期业绩 股东应占溢利942.3万美元 同比减少44.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658997318","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658997318?lang=zh_cn&edition=full","pubTime":"2026-08-11 19:36","pubTimestamp":1786448173,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1212","03839"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168412409","title":"正大生物（03839）发布中期业绩：上半年股东应占溢利9,423千美元，同比减少44.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1168412409","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1168412409?lang=zh_cn&edition=full","pubTime":"2026-08-11 19:35","pubTimestamp":1786448147,"startTime":"0","endTime":"0","summary":"正大生物控股有限公司8月11日公布，截至2026年6月30日止六个月未经审计的综合业绩。报告期内，集团收入为211,389千美元，同比下降34.6%；毛利34,728千美元，同比减少16.9%。期内，集团整体毛利率由上年同期的12.9%提高至16.4%。除税前溢利为13,455千美元，同比减少44.4%；所得税开支3,306千美元，同比减少21.6%。期内溢利10,149千美元，其中本公司股东应占溢利9,423千美元，同比减少44.7%；每股基本及摊薄溢利皆为3.70美仙。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03839"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178262172","title":"正大生物7月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1178262172","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1178262172?lang=zh_cn&edition=full","pubTime":"2026-08-03 19:07","pubTimestamp":1785755232,"startTime":"0","endTime":"0","summary":"正大生物于2026年8月3日发布2026年7月31日止月度证券变动报告，公司注册名称为正大生物控股有限公司。本次报告期内，各类股份数量及注册股本均未发生变动。公司已发行普通股数量依旧为240,718,310股，且不存在库藏股；已发行可换股优先股数量仍为12,610,777股。公司现有购股权计划未有行权、授予或失效记录，期内未因行使期权产生新股或库藏股变化，目前根据此计划可能发行或转让的股份总数为24,071,831股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03839"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103808332","title":"正大生物（03839）拟于8月11日召开董事会 审议2026年中期业绩及分红事宜","url":"https://stock-news.laohu8.com/highlight/detail?id=1103808332","media":"公告速递","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103808332?lang=zh_cn&edition=full","pubTime":"2026-07-28 19:11","pubTimestamp":1785237085,"startTime":"0","endTime":"0","summary":"正大生物7月28日公告，公司董事会将于2026年8月11日（星期二）召开会议，主要议程包括：。公司表示，香港交易及结算所有限公司及香港联合交易所有限公司对本公告内容概不负责，并且对其准确性或完整性不作任何声明，也不会就因本公告全部或任何部分内容而引致的任何损失承担责任。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03839"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654098960","title":"正大企业国际(03839.HK)拟8月11日举行董事会会议以审批中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2654098960","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654098960?lang=zh_cn&edition=full","pubTime":"2026-07-28 19:07","pubTimestamp":1785236822,"startTime":"0","endTime":"0","summary":"格隆汇7月28日丨正大企业国际(03839.HK)公告，将于2026年8月11日(星期二)举行董事会会议，藉以(其中包括)批准公司及其附属公司截至2026年6月30日止6个月中期业绩及考虑派发中期股息(如有)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260728/32319863.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["03839","BK1212"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653754423","title":"正大企业国际(03839)发盈警，预期中期股东应占综合溢利约为950万美元 同比减少","url":"https://stock-news.laohu8.com/highlight/detail?id=2653754423","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653754423?lang=zh_cn&edition=full","pubTime":"2026-07-22 19:01","pubTimestamp":1784718082,"startTime":"0","endTime":"0","summary":"智通财经APP讯，正大企业国际(03839)发布公告，本集团预期截至2026年6月30日止6个月(2026年6个月)取得股东应占综合溢利约为950万美元，相比截至2025年6月30日止6个月(2025年6个月)则取得1700万美元。溢利的下降主要是由于集团的金霉素和动保业务业绩受中国养殖行情低迷拖累。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1471009.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1212","03839"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653675442","title":"正大企业国际(03839.HK)发盈警，预期中期股东应占综合溢利约为950万美元 同比减少","url":"https://stock-news.laohu8.com/highlight/detail?id=2653675442","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653675442?lang=zh_cn&edition=full","pubTime":"2026-07-22 19:01","pubTimestamp":1784718082,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["03839","BK1212"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195514920","title":"正大企业国际（03839）发布盈利警告：预计2026年上半年股东应占溢利同比降44%至约950万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1195514920","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1195514920?lang=zh_cn&edition=full","pubTime":"2026-07-22 19:00","pubTimestamp":1784718033,"startTime":"0","endTime":"0","summary":"正大企业国际（03839）7月22日公告，根据初步数据显示，公司预期截至2026年6月30日止六个月录得股东应占综合溢利约950万美元，而去年同期（截至2025年6月30日止六个月）则为1,700万美元，同比减少约44.1%。\n公司表示，业绩下滑主要因金霉素及动保业务受中国养殖行情低迷影响所致。\n公告同时指出，公司正在编制2026年上半年未经审核综合业绩，并计划于2026年8月中旬公布正式中期业绩。\n公司提醒股东及潜在投资者在买卖公司股份时保持审慎。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03839"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123659839","title":"正大企业国际预计上半年利润下滑 主因中国养殖业放缓","url":"https://stock-news.laohu8.com/highlight/detail?id=1123659839","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1123659839?lang=zh_cn&edition=full","pubTime":"2026-07-22 19:00","pubTimestamp":1784718015,"startTime":"0","endTime":"0","summary":"正大企业国际（CT ENTERPRISE）预期其上半年利润将出现下降，主要归咎于中国动物养殖行业增长放缓带来的影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03839","BK1212"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185618534","title":"正大企业国际预计2026年上半年股东应占溢利950万美元，较2025年同期1700万美元下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=1185618534","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1185618534?lang=zh_cn&edition=full","pubTime":"2026-07-22 19:00","pubTimestamp":1784718011,"startTime":"0","endTime":"0","summary":"正大企业国际发布业绩预告，预计2026年上半年归属于公司股东的净利润将达到950万美元，相较于2025年同期的1700万美元，录得显著下降。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03839","BK1212"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652901022","title":"正大企业国际(03839)中文名称变更为“正大生物控股有限公司”","url":"https://stock-news.laohu8.com/highlight/detail?id=2652901022","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652901022?lang=zh_cn&edition=full","pubTime":"2026-07-20 19:20","pubTimestamp":1784546433,"startTime":"0","endTime":"0","summary":"香港公司注册处处长于2026年7月13日发出注册非香港公司变更名称注册证明书，确认根据公司条例第16部于香港注册新英文名称“CPBIO Holding Company Limited”及新中文名称“正大生物控股有限公司”。自2026年7月24日上午9时正起，于联交所买卖股份的英文股份简称将由“CT ENTERPRISE”更改为“CPBIO”，而中文股份简称将由“正大企业国际”更改为“正大生物”。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1469913.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03839","BK1212"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135081957","title":"正大企业国际6月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1135081957","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1135081957?lang=zh_cn&edition=full","pubTime":"2026-07-02 18:41","pubTimestamp":1782988918,"startTime":"0","endTime":"0","summary":"正大企业国际有限公司于2026年7月2日发布了截至2026年6月30日的股份变动月报表。报告显示，公司当月未发生任何新增发行、买回、注销或库藏股变动，股本总体保持稳定。至6月末，两项股本均与上月底持平，整体法定/注册股本总额依然为USD 80,000,000。根据公告，正大企业国际当月并没有进行股份期权授出、行使或失效等变动，购回与注销活动亦未发生。公司表示，截至2026年6月30日，现有普通股与优先股数量与上一个月底一致，总体股本维持稳定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03839"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191425499","title":"正大企业国际2026年5月股份变动月报：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1191425499","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191425499?lang=zh_cn&edition=full","pubTime":"2026-06-01 11:02","pubTimestamp":1780282921,"startTime":"0","endTime":"0","summary":"正大企业国际有限公司于2026年6月1日发布2026年5月股份变动月报表。报告期为2026年5月，截至本月末，公司普通股与可换股优先股的已发行股份数及注册股本未发生变化。此外，公司于月报中确认，普通股维持符合香港联交所的上市规则所规定的公众持股量要求。公司于2025年6月10日获股东大会通过设立购股权计划，目前可供行使的股份期权数量为24,071,831股，报告期内无新增授出、行使或失效记录。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03839"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634290784","title":"正大企业国际(03839)一季度股东应占溢利564万美元 同比减少26.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2634290784","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2634290784?lang=zh_cn&edition=full","pubTime":"2026-05-12 18:42","pubTimestamp":1778582579,"startTime":"0","endTime":"0","summary":"智通财经APP讯，正大企业国际(03839)发布截至2026年3月31日止3个月业绩，收入9897.2万美元，同比减少40.03%;公司股东应占溢利564万美元，同比减少26.64%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1440783.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03839","BK1212"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141689009","title":"正大企业国际4月股份变动月报表，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1141689009","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1141689009?lang=zh_cn&edition=full","pubTime":"2026-05-04 16:38","pubTimestamp":1777883921,"startTime":"0","endTime":"0","summary":"正大企业国际于2026年5月4日发布截至2026年4月30日止的股份变动月报表。根据公告，报告期内公司普通股及可换股优先股的注册股本、已发行股份总数与上月末保持一致，未涉及新增发行、购回或注销行为，整体股本结构保持稳定。根据月报中披露的信息，正大企业国际已就公共持股量达标作出确认，符合香港联合交易所有限公司的上市规则要求。本次公告由公司秘书刘永源签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03839"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135117342","title":"正大企业国际授予董事股份购回授权 规模达已发行股本一成","url":"https://stock-news.laohu8.com/highlight/detail?id=1135117342","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1135117342?lang=zh_cn&edition=full","pubTime":"2026-04-29 18:22","pubTimestamp":1777458150,"startTime":"0","endTime":"0","summary":"正大企业国际在香港联合交易所披露公告，公司董事会已提呈一项股份购回授权方案，拟在获股东批准后，回购最多相当于已发行股份总数10%的股份。公告显示，此次授权旨在提升股东回报并增强公司资本结构。董事会认为，回购股份将符合公司及股东整体利益。公司股份登记将于2026年6月4日至9日暂停办理过户手续，以确定具备表决权的股东名单。董事会表示，将根据市况及公司资金状况决定是否行使授权。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"正大企业国际授予董事股份购回授权 规模达已发行股本一成","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03839"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183823851","title":"正大企业国际2025年收入同比增长74%，生物科技与动物健康业务显著带动盈利提升","url":"https://stock-news.laohu8.com/highlight/detail?id=1183823851","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1183823851?lang=zh_cn&edition=full","pubTime":"2026-04-29 18:20","pubTimestamp":1777458055,"startTime":"0","endTime":"0","summary":"正大企业国际于2025年度在全球经济低速增长及高利率环境的挑战下，依托稳健经营理念与长期愿景，实现了收入和盈利的全面增长。根据年报披露，集团全年收入从上年度的3.08亿美元增至5.36亿美元，同比上涨74.13%；本公司股东应占溢利上升至3,205.5万美元，较2024年度的1,116.8万美元大幅增长186.92%。同期经营活动所产生的现金流亦显著改善，同比增幅达逾200%。报告期内，生物科技与动物健康板块为主要增长动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"正大企业国际2025年收入同比增长74%，生物科技与动物健康业务显著带动盈利提升","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03839"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630367097","title":"正大企业国际(03839.HK)拟5月12日举行董事会会议审批第一季度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2630367097","media":"中金财经","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2630367097?lang=zh_cn&edition=full","pubTime":"2026-04-27 18:27","pubTimestamp":1777285623,"startTime":"0","endTime":"0","summary":"格隆汇4月27日丨正大企业国际(03839.HK)宣布，将于2026年5月12日举行董事会会议，藉以批准公司及其附属公司截至2026年3月31日止三个月之未经审核业绩。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260427/32180123.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["03839","BK1212"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629401720","title":"正大企业国际(03839.HK)：预计第一季度纯利550万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2629401720","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2629401720?lang=zh_cn&edition=full","pubTime":"2026-04-22 18:37","pubTimestamp":1776854222,"startTime":"0","endTime":"0","summary":"格隆汇4月22日丨正大企业国际(03839.HK)公告，集团预期截至2026年3月31日止三个月录得股东应占综合溢利约为550万美元，相比截至2025年3月31日止三个月则录得770万美元。溢利的下降主要是由于金霉素产品利润贡献下降所致。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260422/32164657.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1212","03839"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ctei.com.hk","stockEarnings":[{"period":"1week","weight":-0.02},{"period":"1month","weight":-0.0628},{"period":"3month","weight":0.016},{"period":"6month","weight":0.2779},{"period":"1year","weight":0.1588},{"period":"ytd","weight":0.1828}],"compareEarnings":[{"period":"1week","weight":0.0119},{"period":"1month","weight":0.0225},{"period":"3month","weight":0.0036},{"period":"6month","weight":-0.0271},{"period":"1year","weight":0.0212},{"period":"ytd","weight":0.0027}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"正大企业国际有限公司为一家主要从事生化业务的公司。该公司通过两个分部运营业务。生化业务分部主要从事制造及销售动保化药产品及金霉素。工业业务分部主要从事机械设备贸易及产销汽车零部件。","yearOnYearQuotes":[{"month":1,"riseRate":0.545455,"avgChangeRate":0.545545},{"month":2,"riseRate":0.2,"avgChangeRate":-0.07481},{"month":3,"riseRate":0.272727,"avgChangeRate":-0.012071},{"month":4,"riseRate":0.363636,"avgChangeRate":-0.030248},{"month":5,"riseRate":0.545455,"avgChangeRate":0.014106},{"month":6,"riseRate":0.454545,"avgChangeRate":0.128129},{"month":7,"riseRate":0.545455,"avgChangeRate":0.031502},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.047253},{"month":9,"riseRate":0.363636,"avgChangeRate":0.03457},{"month":10,"riseRate":0.272727,"avgChangeRate":0.00957},{"month":11,"riseRate":0.545455,"avgChangeRate":0.007665},{"month":12,"riseRate":0.363636,"avgChangeRate":-0.030461}],"exchange":"SEHK","name":"正大生物","nameEN":"CPBIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"正大生物(03839)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供正大生物(03839)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"正大生物,03839,正大生物股票,正大生物股票老虎,正大生物股票老虎国际,正大生物行情,正大生物股票行情,正大生物股价,正大生物股市,正大生物股票价格,正大生物股票交易,正大生物股票购买,正大生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"正大生物(03839)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供正大生物(03839)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}